Raymond Anderson
Fortune : 349 460 $ au 31/05/2026
Fortune : 349 460 $ au 31/05/2026
Raymond W.
Anderson is an Independent Director at Monopar Therapeutics, Inc. since 2017.
Former positions include Managing Director at Dow Pharmaceutical Sciences, Inc. from 2009 to 2010, Independent Director at Horizon Pharmaceutical LLC from 2012 to 2016, Chief Operating & Financial Officer at BioMarin Pharmaceutical, Inc. from 1998 to 2001, Director at Raptor Pharmaceuticals Corp., Principal at Chiron Corp., Glycomed, Inc., Syntex Corp., and Fusion Medical Technologies, Inc., Chief Financial Officer at ProRhythm, Inc., and Finance Manager at Memorex Corp.
Education includes an MBA from Harvard University, graduate studies at George Washington University, and undergraduate studies at the US Military Academy.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 5 373 ( 0,08% ) | 349 460 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Directeur/Membre du Conseil | 01/04/2017 |
| Sociétés | Poste | Fin |
|---|---|---|
| RAPTOR PHARMACEUTICAL CORP | Directeur/Membre du Conseil | 25/10/2016 |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes topical drug products | Directeur Financier/CFO | 01/01/2009 |
| BIOMARIN PHARMACEUTICAL INC. | Directeur Financier/CFO | 01/01/2001 |
Memorex Corp.
Memorex Corp. Information Technology ServicesTechnology Services Provides information technology solutions | Corporate Officer/Principal | - |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 14 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Glycomed, Inc.
Glycomed, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceuticals based on complex carbohydrates | Health Technology |
Syntex Corp.
Syntex Corp. Pharmaceuticals: MajorHealth Technology Pharmaceutical concern | Health Technology |
Fusion Medical Technologies, Inc.
Fusion Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops surgical sealants for the treatment of surgical wounds | Health Technology |
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
ProRhythm, Inc.
ProRhythm, Inc. Medical SpecialtiesHealth Technology Provides medical services | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
George Washington University
George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dow Pharmaceutical Sciences, Inc.
Dow Pharmaceutical Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes topical drug products | Health Technology |
US Military Academy
US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
Memorex Corp.
Memorex Corp. Information Technology ServicesTechnology Services Provides information technology solutions | Technology Services |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national